工程化食品源益生菌提供检查点抑制剂调节器
Muhammad Shahid Mehmood1, Malaika Masood2, Naseeb Danaf3
1Faculty of Veterinary Science, Institute of Microbiology, University of Agriculture Faisalabad, Faisalabad, Pakistan.
Annals of medicine and surgery (2012)
|January 7, 2026
概括
工程益生菌提供了一种新的癌症免疫治疗方法. 这些食源性微生物在临床前和临床研究中显示出显著的瘤减少和更好的生存率.
科学领域:
- 关于微生物学的论文
- 合成生物学 合成生物学
- 癌症免疫疗法癌症免疫疗法
背景情况:
- 工程化食品传播益生菌融合了合成生物学,营养和癌症免疫治疗.
- 临床前研究表明,工程益生菌具有强大的抗瘤作用.
研究的目的:
- 为了评估工程性食源益生菌作为癌症免疫疗法平台的有效性.
- 评估肠道微生物群多样性对免疫治疗反应的影响.
主要方法:
- 在临床前模型中使用了工程 *Lactococcus lactis*, *Escherichia coli Nissle 1917* 和 *Lactobacillus plantarum*.
- 进行了关于肠道微生物群多样性和免疫治疗的临床数据的元分析.
- 在非小细胞肺癌 (NSCLC) 患者中进行了I期临床试验.
主要成果:
- 在小鼠中,工程益生菌显示显著减少瘤生长 (高达64%) 和完全瘤回归 (50%).
- 观察到CD8+ T细胞透和NK细胞活性增加.
- 肠道微生物群的多样性与检查点抑制剂反应增加40%以及无进展生存期增加12个月相关.
- 在NSCLC的第一阶段试验显示,免疫相关性结肠炎减少,益生菌联合治疗的响应率更高.
结论:
- 工程化食品传播益生菌代表了一个有前途的,低毒性的免疫治疗平台.
- 基因电路的进步提高了可食用生物的潜力.
- 需要进一步的研究来应对殖民化和生物安全方面的挑战.
相关概念视频
01:29Microorganisms in Medicine and Therapeutics
928
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
928
01:29Inflammatory Bowel Disease IV: Pharmacological Management
471
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
471
01:05Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
193
Body:Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...
193
01:28Biological Methods for Microbial Control
776
Biological agents offer an effective means of controlling microbial growth by leveraging natural processes like predation, competition, and the secretion of antimicrobial substances.Predatory bacteria such as Bdellovibrio species target and kill pathogens like Salmonella and E. coli. They are widely used in poultry farms to control infections. Myxococcus species help combat plant-pathogenic fungi. These naturally occurring predators serve as eco-friendly alternatives to chemical pesticides and...
776
01:18Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents
412
Acute diarrhea, a common gastrointestinal disturbance, is characterized by the rapid evacuation of fluid stools, leading to an excessive weight in fluid. This condition typically arises from disorders affecting intestinal water and electrolyte transport. It can be triggered by an increased osmotic load within the intestine, excessive secretion of electrolytes and water, mucosal exudation of protein and fluid, or altered intestinal motility. The primary risks of acute diarrhea are dehydration...
412
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
631
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
631